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Abstract
Effects of low maternal aldosterone on offspring cardiovascular development.
Travis McKee, M.S. Biology, Minnesota State University, Mankato, MN 2012

Maternal conditions are well known to affect fetal cardiovascular development. This
study was designed to investigate in spontaneously hypertensive rats (SHR), the effects of
maternal aldosterone suppression on the development of hypertension in the offspring. A sham
procedure or a right adrenalectomy combined with cryodestruction of the zona glomerulosa of
the left adrenal gland was performed on SHR females. The rats were mated and male offspring
were implanted at 11-13 weeks of age with a PA-C40 remote monitoring device placed into the
femoral artery to record cardiovascular parameters for 4 weeks. Systolic (mmHg), diastolic
(mmHg), and mean blood pressure (mmHg), heart rate (beats per minute), and activity data was
measured. Data was sorted by activity level, and parameters were compared to evaluate same
age data points between freeze and sham groups. Continuous scatterplot with regression lines
compared activity level versus mean pressure, pulse pressure, and heart rate for each of the four
weeks of data collection. The slopes and elevations of the regression lines from the sham and
frozen groups were compared using a two-way ANOVA. Reductions in maternal aldosterone
concentrations in the adrenal frozen group led to changes in adult offspring hemodynamic
profiles. The adult offspring of the adrenal frozen group were found to have an attenuated
increase in mean pressure with activity during weeks 2 and 3, and an overall lower mean
pressure during week 4. It appears that a difference in sympathetic activation was likely
responsible for the differences between groups, and this fetal programming effect has not been
observed with other maternal manipulations.
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Chapter I
Introduction
Cardiovascular disease (CVD) is the leading cause of death for both men and women in
the United States. The Center for Disease Control and Prevention (CDC) reports that in the U.S.
approximately 26% of the annual mortality rate is caused by coronary heart disease-related
illness (1). In 2010, the United States spent approximately $316.4 billion dollars on
cardiovascular disease related-care including the cost of health care services, medications, and
loss of productivity (2). The proliferation of obesity in children and adolescents is also predicted
to increase the cost of health care in the upcoming decades due to the rising number of adults that
will require heart disease and type 2 diabetes related care (3). Hypertension is a major
underlying determinant of cardiovascular disease, affecting approximately one in three adults in
the U.S. (2). National Vital Statistics Survey (NVSS) reports that hypertension contributes to
one out of every seven deaths in the United States each year (1). Hypertension additionally
contributes to nearly half of all deaths related to cardiovascular disease (1).
Guyton et al. (1964) suggested a potential link between a reduction in renal sodium
excretion and the pathogenesis of hypertension. The study found that the kidneys play an
important role in the origin and maintenance of hypertension (4). Thornburg and colleagues
found that a family history of hypertension and obesity are both risk factors commonly
associated with the development of hypertension (5). The role of family history on hypertension
and obesity in the renal handling of sodium was also evaluated. Both obese and lean adolescent
children of hypertensive parents had increased proximal tubular sodium reabsorption in the
nephron, which increased the likelihood of hypertension development (6). Woods and
colleagues additionally used a rat model to demonstrate that the renin-angiotensin-aldosterone
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system (RAAS), involved in sodium reabsorption through the action of aldosterone, can
contribute to the development of adult hypertension (7). These studies support the theory that
hypertension is caused by defects in sodium and fluid balance.
While people have the ability to decrease their risk of developing coronary heart disease
through diet, exercise, and maintaining a healthy lifestyle, epidemiological evidence examining
the association between birth weight and hypertension has demonstrated that slow rates of
prenatal growth can significantly predict the likelihood of cardiovascular disease development
(8). Furthermore, the correlation between blood pressure and birth weight appears to increase as
a person ages (9). Fetal undergrowth may occur as a result of placental inadequacies (8). In
addition, the nutritional and hormonal environment of the fetus is correlated with low birth
weight and the subsequent development of hypertension and cardiovascular disease in adulthood
(10). Events during fetal development have been shown to have long lasting impacts on tissue
structure and function (9, 11, 12, 13).
Maternal conditions involving alterations of the RAAS or other adrenal hormones affect
fetal development and subsequent offspring cardiovascular disease risk. Several studies suggest
that the adrenal cortex hormones can contribute to renal defects of the maternal kidneys and
produce hypertension in their offspring through the action of the RAAS (7, 11, 14). Low sodium
diets in maternal rats have been shown to cause elevated aldosterone levels in the maternal and
fetal blood, intrauterine growth restriction, and an increase blood pressure in the offspring (15,
16). Sodium depletion in maternal rats results in offspring that have a greater salt appetite, an
effect shown to be dependent on the resultant elevation in the RAAS (17). Fetal synthesis of
aldosterone is not present prior to day 18 of gestation, and the source of fetal aldosterone for
most of the gestational period is from the maternal blood (18). Aldosterone crosses the maternal
2

feto-placental barrier, and therefore can affect fetal development (18). Through hormones
including aldosterone, the kidney and adrenal gland are able to regulate gene expression, growth,
and maturation of the fetus (11, 19).
Since it is established that intrauterine conditions can alter fetal development, and
aldosterone appears to play a role in the development of hypertension, the current study will
investigate the effects of maternal aldosterone suppression on the development of hypertension
in spontaneously hypertensive rat (SHR) male offspring. There have been no previous studies
that have investigated the effects of reduced maternal aldosterone on the development of
hypertension in offspring. The current study, which uses maternal SHR subjected to a unilateral
adrenalectomy and contralateral zona glomerulosa cryodestruction, is unique. The adrenal
freezing will suppress only aldosterone because its synthesis and release is exclusive to the zona
glomerulosa (20). However, this model allows aldosterone to respond to physiological
stimulators/inhibitors, while levels remain at approximately 30% of normal (21). Other prenatal
programming or intrauterine growth restriction (IUGR) studies aimed at investigating the effects
of both the RAAS and aldosterone during fetal development have not used a surgical strategy
that reduces the release of aldosterone secretion without disturbing other hormones synthesized
in the adrenal cortex. A reduction in maternal aldosterone is likely to result in a lowered blood
volume during pregnancy, which is predicted to elevate blood pressure in the adult offspring of
the adrenal frozen rats as a result of intrauterine growth restriction from the compromised
nutrient and hormonal environment in utero.
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Chapter II
Literature Review
Hypertension
High blood pressure, otherwise known as hypertension, is the principal factor
contributing to the morbidity and mortality associated with coronary heart disease, stroke, and
kidney failure (22, 23). Arterial hypertension is characterized by having a level of blood
pressure at 140/90 mmHg or higher, and is hypothesized to be associated with both genetic and
environmental factors (23, 24). The correlation between blood pressure and hypertension is
more related to the systolic measurement than the diastolic pressure measurement (22). General
characteristics of essential hypertension, which without a defined underlying cause, include:
increased vascular stiffness, increased vascular resistance, and increased vascular responsiveness
to stimuli (23). Blood pressure is determined by both taking the product of cardiac output and
peripheral vascular resistance, which regulates arteriolar blood flow into the capillaries (25).
Therefore, the pressure is determined by the amount of blood being pumped from the heart into
the circulatory bed (cardiac output), and the vascular tone or level of constriction applied on the
arteries (systemic vascular resistance) (22). Total peripheral resistance, or the overall vascular
tone, may be elevated due to an increased release of peptides such as angiotensin, endothelins, or
increased α-adrenoceptor stimulation (23).
The cardiac output is determined by the stroke volume and the heart rate (22). If the
heart rate and/or the stroke volume increase, then cardiac output will increase as well. The
increase in cardiac output associated with hypertension arises from an increase in fluid volume,
or from an increase in contractility correlated with neural stimulation of the heart (22).
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The autonomic nervous system is also important for the control of blood pressure. The
sympathetic branch increases heart rate, stroke volume, and vascular resistance to raise blood
pressure. The parasympathetic branch tends to decrease heart rate and lower blood pressure. In
patients with hypertension there is often an increased peripheral sensitivity to the sympathetic
neurotransmitter norepinephrine, and an increased responsiveness to physiological stressors (22,
23).
The activation of the renin-angiotensin-aldosterone system (RAAS) also increases
angiotensin II in blood to cause vasoconstriction, which results in a rise in vascular resistance
and an elevated blood pressure. Angiotensin II stimulates the release of aldosterone from the
adrenal cortex, which acts on the kidneys to cause salt/water retention, an increase in blood
volume, and an increase in cardiac output (26). Blood pressure at the kidney controls for fluid
retention independent of hormonal influence, and is the dominant mechanism for long-term
blood pressure control. Therefore, when blood pressure rises, body fluid volume drops in order
to reduce blood pressure at the level of the kidneys to normal (27). The increased sodium
excretion in response to a rise in blood pressure is known as pressure natriuresis (23).

Kidney Function
The kidney excretes metabolic waste products and maintains plasma osmolarity (28).
The kidney contains functional units called nephrons that filter plasma, reabsorb water and
nutrients, and secrete wastes. The nephron contains a tubule that extends from structure in the
kidney called the renal corpuscle, consisting of the Bowmann’s capsule and glomerulus, which
filters fluid (filtrate) out of the blood and into the tubule (28). The filtrate is altered by selective
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reabsorption, and water and nutrients not reabsorbed back into the kidney tubules are excreted in
the urine (29). Regulation of reabsorption is under the control of several hormones, including
ADH (antidiuretic hormone), atrial natriuretic peptide (ANP), ANG II, and aldosterone (30).
ADH promotes the reabsorption of water through the insertion of channels which allow for the
movement of water through the cell membranes of the collecting duct, back into the capillaries
(28). Aldosterone increases potassium secretion and sodium reabsorption (20, 22).
Because the regulation of sodium and water are necessary to maintain fluid balance, the
kidneys are important for long term control of blood pressure (30). There are two mechanisms
that regulate sodium handling in the kidney. One mechanism regulates fluid volume by
increasing or decreasing the excretion of sodium and water which changes the renal perfusion
pressure. This mechanism is also called pressure natriuresis (23, 29). The second mechanism
utilizes the renin-angiotensin-aldosterone system to directly control peripheral resistance and the
renal reabsorption of sodium and water through the action of aldosterone (29). At the distal
tubule, aldosterone acts to increase sodium reabsorption, and is involved in fluid retention and
blood pressure regulation. Excess secretion of aldosterone enhances sodium reabsorption, and
can lead to the development of hypertension by increasing blood volume and cardiac output (31).

Renin-Angiotensin-Aldosterone System (RAAS)
The renin-angiotensin-aldosterone system (RAAS) plays an important role in salt and
water homeostasis (12, 20, 32, 33). The RAAS is an important system in the development of
hypertension. Based on the commonly understood RAAS cascade, depressed levels of renin
secretion will decrease angiotensin I (ANG I) and II production, reduce aldosterone secretion,
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and decrease blood pressure. Renin belongs to a family of aspartyl proteases that is highly
specific for angiotensinogen (33). Renin secretion is influenced by the pressure of the renal
artery via the vascular baroreceptor (12). Over and underproduction of the enzyme renin results
in disturbances in plasma osmolarity and volume, and alterations in blood pressure (33). The
majority of renin synthesis occurs in the kidney; however, several other organs including the
brain, pituitary, adrenal glands, and arterial smooth muscle also contribute small amounts (12).
Angiotensinogen is converted to angiotensin I (ANG I) by renin, and angiotensin I is
converted to angiotensin II (ANG II) by angiotensin converting enzyme (ACE), located on the
pulmonary vascular endothelium (32). Angiotensinogen is a glycoprotein stored and released by
the liver (34). Angiotensin II stimulates the release of aldosterone from the adrenal cortex,
which regulates sodium reabsorption in the kidney. The release of angiotensinogen is also
stimulated by ANG II (33).
ANG II can stimulate plasma aldosterone secretion through the RAAS cascade.
Aldosterone acts to increase sodium reabsorption and potassium excretion in the distal tubule of
the kidney. Sodium reabsorption is known to increase blood volume and blood pressure (32).
ANG II secretion would be expected to be accompanied by increases in plasma aldosterone.
Plasma aldosterone concentrations were compared in rats administered ANG II under salt
loading and normal conditions (32). Plasma aldosterone concentrations did not change,
regardless of ANG II administration. Therefore, small increases of ANG II do not necessarily
lead to an increase in plasma aldosterone levels, indicating a more complex regulation process
for aldosterone release (32).
Sodium-intake variations are likely to influence plasma aldosterone concentrations.
Wambach et al. (1982) observed the aldosterone excretion of 100 hypertensive patients fed a
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high-sodium diet (35). The first group of patients (n=64) had suppressed aldosterone excretion
similar to the normotensive control patients. The second group (n=36) had aldosterone levels
above the control patients and serum potassium levels were lower than the first group of patients
despite forced sodium loading. However; the second group responded better to spironolactone
(aldosterone receptor antagonist) treatment to reduce blood pressure, and ANG II infusion was
found to elevate plasma aldosterone level in both groups. Sodium loading may cause
fluctuations in aldosterone concentrations which can resemble a normotensive patient, or a
patient with hypertension (35).

Adrenal Cortex
The adrenal cortex consists of the outer portion of the adrenal gland. The cortex secretes
hormones that potentiate certain chemicals in the blood, affect the rate of metabolism, and can
cause changes in growth. The adrenal cortex secretes glucocorticoid and mineralocorticoid
steroid hormones directly into the bloodstream (36). The cortex contains three distinct layers
which release various steroid hormones: the innermost zona reticularis, the middle zona
fasciculata, and the outer zona glomerulosa. The zona reticularis and fasciculata produce
androgens and glucocorticoids, respectively. The zona glomerulosa secretes aldosterone (36).
Both corticosterone and aldosterone have been linked with hypertension.
Cortiocosterone is secreted in response to stress, stimulated by ACTH from the anterior pituitary
(20, 36, 37). Increases in corticosterone have been associated with increased cardiovascular risks
including the development of hypertension (33). Aldosterone acts to increase the retention of
sodium and water in the kidneys, therefore it also plays an important role in the development of
hypertension (20). Sodium depletion or potassium elevation results in stimulation of aldosterone
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secretion. The zona glomerulosa has been found to hypertrophy following sodium reductions
and/or elevations in potassium, and the cells become hypersensitive to ANG II under these
conditions (38). Studies have found that aldosterone reduction may inhibit or delay the
development of hypertension by decreasing blood volume and blood pressure (14, 20).
Aldosterone exerts its activity by binding to the mineralocorticoid receptor (MR). Corticosteroid
is able to bind the same receptor; however, 11 beta-HSD type 2, co-localized with the MR
receptor, inactivates glucocorticoids, thus preventing inappropriate activation (37).

Hypertension and Prenatal Programming
Hypertension, insulin resistance, type 2 diabetes, and other factors linked to
cardiovascular disease are commonly associated with lifestyle choices in adulthood (13).
However, an increasing body of epidemiological evidence suggests that the nutritional and
hormonal environment of the fetus is correlated with low birth weight and the subsequent
development of hypertension and cardiovascular disease in adulthood (10). Events during fetal
development have been shown to have long lasting impacts on tissue structure and function (9,
11, 12, 13). The association between the development of hypertension, type 2 diabetes, and
cardiovascular disease with reduced fetal growth has been found to be independent of life styleassociated risk factors including smoking, obesity, alcohol consumption, and socioeconomic
status (39).
Reduced fetal growth has been associated with an increased risk for hypertension (8)
Barker showed that the mean systolic and diastolic blood pressure of men and women was
elevated in the cohort with low placental weights. Low placental weight was found to be
associated with low birth weight (8). Evidence of birth weight on the development of
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hypertension is further supported using data from individuals with birth weights within normal
ranges (40, 41). These studies found that individuals with normal birth weights were less likely
to develop hypertension independent of lifestyle choices. Gluckman et al. (2004) used identical
twin birth weight data to investigate the development of hypertension in adulthood (42). The
twin with the lowest birth weight was found to have the highest blood pressure as an adult. The
growing body of research showing the significance of prenatal programming on the development
of hypertension does not suggest that birth weight is the direct cause of disease, rather that fetal
programming processes are a major contributing factor to the prevalence and development of
disease (42, 43).

Maternal Protein Deficiency and Prenatal Programming
Maternal protein deficiency appears to be important in fetal growth restriction and the
development of hypertension in the offspring (11, 44, 45). Under moderate protein restriction,
an increase in offspring blood pressure by 20-30 mmHg was found (11). The hypertensive effect
was mediated by exposure to an excess of maternal glucocorticoids as a result of an 11-betaHSD 2 deficiency in the placenta. 11-beta HSD2 converts corticosterone to an inactive form, 11dehydrocorticosterone, and protects the fetus from being exposed to excess corticosterone (11).
Benediktsson et al. (1993) suggested that corticosterone excess during fetal development is
associated with low offspring birth weight. The low birth weight described is closely associated
with the development of cardiovascular disease in adulthood (43, 46).
McMullen et al. (2004) also investigated the offspring of low-protein fed mothers.
Pregnant WKY rats were fed a control diet or a low-protein diet during gestation (45). The
10

nephron number in kidneys in 4 week old offspring was significantly reduced under maternal
protein restriction. These offspring had greater systolic blood pressure than controls. The
offspring of low-protein fed mothers also had low renal expression of the angiotensin II type 2
receptor, and elevated blood pressures. The type 2 receptor tends to have the opposite effect on
sodium retention as the more prevalent angiotensin II type 1 receptor. The authors suggest that
the lower expression of this receptor may be important for renal development impairment and
hypertension exhibited in the offspring of mothers fed a low-protein diet during pregnancy (45).

The RAAS and Fetal Development
Lumbers (1995) suggested that the renin-angiotensin-aldosterone (RAAS) system varies
significantly during intra-uterine and extra-uterine life. During pregnancy, the fetus is affected
by the mother’s RAAS. The maternal RAAS is activated when there are severe losses in sodium
and fluid volume. The fetal kidneys function to deliver fluid to the amniotic cavity to form
amniotic fluid. The amniotic fluid environment is important to allow for chest cavity movement,
the free movement of limbs, and prevents the uterine wall from wrapping tightly around the fetus
(14). Lumbers also found that ATII levels in fetal sheep are similar to maternal levels and the
fetal RAAS is important for blood pressure maintenance. The study also found that secretion of
aldosterone from the fetal adrenal is only stimulated with high doses of AII (14).
Reductions in maternal sodium intake during pregnancy have been shown to affect the
maternal and fetal RAAS. Several studies have investigated intrauterine growth restriction
(IUGR) and the development of hypertension in rats subjected to an altered maternal sodium diet
(16, 47, 48, 49). Battista et al. (2002) examined blood pressure, RAAS activity, renal function
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and heart and kidney histology in 12 week old offspring born from pregnant rats fed a low
sodium diet, resulting in IUGR offspring (16). Systolic blood pressure was elevated, urinary
sodium excretion was decreased, and aldosterone levels were not found to be correlated with
renin activity in the IUGR male and female adult rats. Based on these findings, the authors
suggested that IUGR-induced offspring of pregnant rats fed a low-sodium diet are prone to
alterations in the RAAS, elevations in blood pressure, and impairments in renal activity in
adulthood (16).
Increases in sodium intake during pregnancy may also affect the RAAS of the offspring.
Ramos et al. (2000) looked at the RAAS response to a salt loading in maternal WKY rats.
Female WKY were either fed a high-sodium (8%), or normal-sodium (1.3%) diet from 8 weeks
of age until the birth of their first litter, and offspring were fed a normal-sodium diet until 12
weeks of age (47). At 12 weeks of age, the offspring were fed either a high-sodium or lowsodium (0.16%) diet for one week to evaluate the RAAS response and sodium excretion. Blood
pressure was significantly higher in the high-sodium mothers than normal-sodium mothers, but
no blood pressure differences in the offspring were observed. Male offspring were found to have
increased blood pressure after one week of high-sodium feeding, but the change was found to be
independent of maternal diet. In female offspring of maternal dams fed a high-salt diet, sodium
excretion was reduced in response to salt overload in the high-salt female offspring, but not in
the normal-salt females. Therefore, the authors concluded that RAAS responsiveness to
maternally-fed high sodium diets are gender specific in the adult offspring. (47).
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Aldosterone and the Fetal Environment
The maternal circulation is the source of aldosterone for the fetus for much of gestation.
The development of the rat adrenal gland in utero was studied using the expression of
aldosterone synthase cytochrome P450 (P450aldo), a functional marker for the expression of
mineralocorticoid-synthesizing zona glomerulosa cells (18). P450aldo was not detected until
gestational day 20, only 2 days prior to birth. However, histological analysis found that zona
glomerulosa cells were present at day 18 (18). The establishment of rat adrenal gland maturation
and cortex zonation was analyzed in utero using markers for the adrenocortical zones (50).
Analysis of the adrenal cell markers showed that functional zonation of the cortex did not
develop until around the time of birth, although cells that synthesize the DNA for adrenal cortex
hormones were found throughout the gland before zonation was established. These findings
suggest that the fetal synthesis of aldosterone is at least not present prior to day 18 of gestation,
and the source of fetal aldosterone is from the maternal circulation.
Decreased maternal sodium intake can increase aldosterone levels in the fetus. Bibeau et
al. (2010) evaluated the expression of proteins and enzymes in the adrenal glands of IUGR rat
fetuses. IUGR fetuses responding to decreased maternal sodium diet were found to have
increased aldosterone concentrations, and were associated with higher adrenal levels of
angiotensin II receptor type 1 and cytochrome P450 aldosterone synthase. It is likely that the
alterations observed in these IUGR fetuses would affect the development of hypertension in
adulthood (15).
Maternal aldosterone deficiency during pregnancy has been found to affect offspring
development in mice (51). During pregnancy, high aldosterone concentrations lead to an
expanded plasma volume, which is important for fetal nutrition. Todkar and colleagues used
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aldosterone synthase deficient pregnant mice to observe the effects of low aldosterone on the
mother and fetus. The study found that maternal systolic blood pressure was low prior to
pregnancy and was further reduced during pregnancy. The aldosterone synthase deficient mice
were found to have smaller litters, and a higher number of necrotic placentas with high
lymphocytic infiltrations at gestational day 18, which indicated a loss of fetuses. A high-sodium
diet administered before and during pregnancy increased systolic blood pressure, improved
differences in fetal and placental weights, and improved litter size. The result suggested that
aldosterone deficiency has strong adverse effects on the fetal environment (51). The study did
not examine the effects of reduced aldosterone on offspring development of hypertension.
Finally, the effect of maternal aldosterone on trophoblast formation and growth and fetoplacental function was investigated (52). Gennari-Moser et al. (2011) hypothesized that low
aldosterone and high cortisol associated with pregnancy-induced hypertension may have an
effect on placental growth and function. Functional deficiency in aldosterone was created in
pregnant mice by spironolactone treatment, a mineralocorticoid receptor antagonist.
Spironolactone treatment led to reduced fetal umbilical blood flow. These findings suggested
that the activation of the mineralocorticoid receptors by maternal aldosterone is required for
normal feto-placental function (52).

The Spontaneously Hypertensive Rat (SHR)
Okamoto et al. (1964) developed the spontaneously hypertensive rat (SHR) strain in
order to provide an animal model of hypertension that requires no surgical or pharmaceutical
treatment. The investigation showed that the SHR underwent pathological changes similar to
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those observed in human hypertension, including nephrosclerosis, vascular damage, and
cardiomegaly (53). Another study found that rats utilize similar mechanisms for sodium
regulation as their human counterparts (54). The portion of the adrenal cortex responsible for the
production and synthesis of aldosterone has been found to be larger in the SHR strain than that of
the normotensive Wistar rat (WKY) strain (55). The differences observed in the size of the zona
glomerulosa (outer adrenal cortex) suggests a link between the action of the RAAS and the
development of hypertension (7, 11, 55, 56).
The intrauterine environment is altered in the SHR (57). Fetal and placental growth and
amniotic fluid composition in SHR and WKY (control) rats was investigated to determine the
role of the intrauterine environment on the development of hypertension in SHR. Fetal and
placental weights of SHR were found to be significantly lower than the WKY controls.
Amniotic fluid volume, sodium concentration, and potassium concentration were significantly
decreased in SHR at gestational day 15 compared to the control group. However, amniotic fluid
sodium concentration was not different in SHR and WKY rats at gestational age 20. It still
remains unclear whether the changes in the placenta and amniotic fluid are of fetal or maternal
origin. It is also unclear how the findings link fetal development to adult blood pressure (57).
The renin-angiotensin-aldosterone system (RAAS) is the primary means to regulate renal
sodium. An excessive retention of sodium has been found to contribute to hypertension
development (33). Mortiz et al. (2000) found that changes in the kidney and handling of renal
sodium are often sex specific, and these differences can result in observed sex differences in
disease outcomes and severity (12). By selecting only male offspring in this study, any influence
that sex has on the development of hypertension can be eliminated.
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Models of Reduced Aldosterone
Reductions in aldosterone, or aldosterone effects are produced by pharmacological,
genetic, or surgical means. Pharmaceutical treatments to reduce aldosterone effects include MR
blockers such as spironolactone or eplerenone, or synthesis inhibitors. Ménard and colleagues
investigated the effectiveness of aldosterone-synthase inhibitors using 8 week old male SHR
(58). The SHR were split into two groups; one fed a low sodium-high potassium diet to induce
high urinary aldosterone, and the other fed a high sodium-normal potassium diet to induce low
urinary aldosterone. FAD 286 A (10 and 30 mg/kg) aldosterone-synthase inhibitor was found to
decrease plasma aldosterone by 53 and 87% on the low sodium diet, and 50 and 87% on the high
sodium diet. Therefore, aldosterone-synthase inhibition appeared effective in reducing
aldosterone in the SHR.
Aldosterone receptor blockers are used to decrease the effects of aldosterone on the
kidney. Ortiz and colleagues evaluated the effects of aldosterone receptor blockade with
eplerenone on renal sodium excretion, blood pressure, plasma aldosterone, and renal ANG II in
rats (59). Eplerenone was found to increase sodium excretion within 24 hours in both
normotensive (control) and SHR rats but, alternate mechanisms for sodium reabsorption were
activated within 5 days to reestablish sodium balance. Eplerenone was found to increase intraadrenal ANG II and aldosterone content. The elevated intrarenal ANG II contributed to sodium
reabsorption, and partially explains the ineffectiveness of the aldosterone-receptor blockade in
lowering systolic blood pressure in ANG II-infused hypertension models (59).
Surgical means to reduce aldosterone include complete adrenalectomy (often with hormone
replacement) and adrenal enucleation. Adrenalectomized pups without steroid replacement
exhibited impaired urinary-concentrating ability, a smaller renal medulla, and a lower medullary
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interstitial osmolality (60). Enucleation of the adrenal involves removing the medulla from the
gland, and allows the cortex to regenerate, eventually producing glucocorticoids and
mineralocorticoids (61).
All models of reduced aldosterone are at least temporarily effective in reducing aldostone
levels or aldosterone effects. However, none of this model allows aldosterone responses to
physiological stimulators, while keeping aldosterone levels below normal. The
adrenalectomy/adrenal freezing procedure developed in this laboratory reduces aldosterone
levels by approximately 70%, while still allowing responses to physiological stimulators such as
low sodium, angiotensin II, or stress (21).

Current Study
The current study was designed to investigate the effects of maternal aldosterone
suppression on the development of hypertension in male offspring. A unique surgical means
involving unilateral adrenalectomy and contralateral adrenal freezing was employed to reduce
aldosterone in the maternal rats. Since reduced aldosterone is likely to result in a lowered blood
volume during pregnancy, much like maternal sodium restriction, a higher blood pressure is
predicted in the adult offspring of the adrenal frozen rats.
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Chapter III

Materials and Methods
From the breeding colony, 8-10 week old SHR females were randomly divided into two
groups, sham or adrenal frozen. A total of 18 maternal SHR from sham (n=10) and adrenal
frozen (n=8) groups were used from the breeding colony at Minnesota State University,
Mankato. All procedures were approved by the IACUC committee (Animal care number: 0404). The SHR were allowed free access to standard rat chow (Lab Diet 5001; Purina Mills,
Brentwood, MO) and tap water. The rats were housed in a constant temperature environment
(20-22˚C) with a 12-hour light-dark cycle. Female SHR were paired with a male SHR for
mating, and allowed to give birth. After the sham/freeze surgical procedure, the SHR females
were reintroduced to a male for a second mating. Offspring of the second mating were studied
beginning at 11-13 weeks of age.

Breeding
The SHR females underwent an initial mating, pregnancy, and parturition prior to the
adrenal sham or freeze procedure. SHR often cannibalize pups from their first litter and
offspring mortality during the first month of life was found to be higher in spontaneously
hypertensive rat strains (50%) than in the WKY control (24%) strain (62). The pups from the
first litter were removed and euthanized three to four days post birth. The maternal rat was then
allowed to recover for 7 to 10 days before undergoing the adrenal freeze or sham surgery.
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Adrenal Freeze/ Sham Surgical Procedures
The maternal SHR underwent either a sham or freeze surgical procedure 7 to 10 days
after removal of the first pups. Half of the rats were subjected to the unilateral
adrenalectomy/adrenal freeze surgery to reduce the production of aldosterone, and half
underwent the sham surgery. The surgical procedures were previously developed in the
laboratory of Dr. Penny Knoblich at Minnesota State University, Mankato, and have been shown
to reduce unstressed aldosterone levels to 30% of normal in pregnant females that were
adrenalectomized/adrenal frozen prior to mating and euthanized on day 20 of gestation (63). The
removal of one gland provided optimal surgical reductions in aldosterone without significantly
influencing corticosterone levels because the remaining gland hypertrophies to compensate (64).
Each maternal rat was weighed in a plastic rectangular anesthetic box to the nearest gram on a
triple beam balance. The following information was recorded in a laboratory notebook: rat, date
of birth, the surgery date, sham/freeze, sex of the rat, and rat identification. Each rat was given a
unique identification prior to the first introduction with a male. All identifications began with
TM, which was followed by a letter designated in alphabetical order based on the rat’s order of
set up. The laboratory notebook was also used to note anything that may have occurred during
the course of, or as a result of the surgery performed.
The rat was anesthetized with 3% isoflurane in oxygen (1 liter/minute flow), pumped into
the plastic anesthetic box into which the rat was placed. Once the rat showed no response to
rotations of the box, the rat was removed from the box and a face mask was taped to the rat’s
nose to supply the anesthetic/oxygen mixture. The oxygen and isoflurane was then readjusted:
the oxygen was set to 0.5 L/min, and the isoflurane to 2.5%. Anesthetic levels were adjusted as
needed to keep the rat at the proper depth of anesthesia.
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Once the face mask was properly secured, the incision area, which includes the dorsal
and lateral sides of the rat’s back over the caudal edges of the ribs, was shaved using an electric
shaver. The shaved hair was removed with a vacuum to eliminate hair from contaminating the
surgical site. The rats were then placed on a standard heating pad that was adjusted as needed to
maintain rectal temperature at 36-37˚C, measured using a thermometer with a rectal probe
(Digital Thermometer; VWR Scientific). The incision area was then scrubbed three times with a
surgical disinfectant (Chlorhexidine Scrub; Priority Care) diluted in water, and was followed
each time by a distilled water rinse. Cleansing started from the site of the incision and moved
outward. Sterile procedure was used by the surgeon. The surgeon scrubbed three times with the
disinfectant soap using a sterile scrub brush. The surgeon then used a sterilized disposable cloth
to dry and sterile disposable gloves were put on both hands. The rat was covered in a sterile
disposable drape with the appropriate sized hole cut over the incision site. All tools used during
the procedures were sterilized by autoclave prior to surgery.

Cryodestruction of the Left Adrenal Zona Glomerulosa
The adrenal freeze procedure consisted of an adrenalectomy on the right side of the rat
combined with the cryo-destruction of the outermost left adrenal gland cortex. An
approximately 2.5cm incision was made through the skin on the left side 3-5mm caudal to the
ribcage using a sterile scalpel (#10). Using blunt dissection with a mosquito forceps, the layers
of muscle located beneath the skin were separated until the internal organs were visible. Once
the internal organs were exposed, a spring type tissue retractor was inserted to hold the skin and
muscle tissue open to facilitate isolation of the adrenal gland. The left adrenal gland was located
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using sterilized cotton swabs to manipulate the viscera. The adrenal gland was then retracted by
using a metal hook that was placed around the adrenal vein and ligaments. Fat was cleaned off
the gland, and a thin metal spatula (5mm wide) was dipped into a solution of liquid nitrogen and
pressed gently against the gland to freeze the outer cortex. Each area of the surface of the gland
was frozen three times, overlapping the sections covered by one application of the spatula to
ensure complete cryodestruction. After the left adrenal gland was frozen, the gland was returned
to its original position inside the body. The adrenal vein was inspected for bleeding before the
incision was closed. The muscle was closed using a sterile absorbable polyglycolic acid suture
(4-0; 3/8 circle cutting needle; Syneture). The skin was then closed with sterile monofilament
nylon suture (4-0; 3/8 circle cutting needle; Henry Shein).

Right Side Adrenalectomy
After completion of the left adrenal freezing, the rat was repositioned onto its left side
with the right side up. The right incision was made identically to the left, 3-5mm caudal to
ribcage. Once the internal organs were again exposed, the adrenal gland was isolated using
gentle dissection with sterile cotton swabs. The adrenal vein was then clamped off using a
mosquito forceps. The adrenal artery, vein, and ligament were cut off distal to the forceps after
time was allowed for venous blood to clot, and the gland was removed. The adrenal vein was
then inspected for bleeding prior to incision closure. The right side incision was closed in the
same manner as the left incision. All rats were given buprenorphine (0.3mg/kg, subcutaneously)
post-surgery to reduce pain.
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Sham Surgery
A sham surgical procedure was performed on the control rats to account for the effects of
surgery alone. SHR were surgically opened using the same procedure as explained in the freeze
group, however this group was sutured closed without any disturbance to the adrenal glands on
either the left or right sides. All rats were given buprenorphine (0.3mg/kg, subcutaneously) postsurgery to reduce pain.

Recovery and Additional Mating
Rats were monitored until they regained consciousness. The rats were housed in
individual cages for 10-14 days, until the rats were fully recovered, and then placed with a male.
The males were removed after 18-20 days, prior to the birth of the pups at the end of the 21 day
gestation period, to prevent the female from getting pregnant while nursing the litter. Once the
breeding males were removed for the second time, the rat cages were monitored for a second
litter of pups. Once born, pups remained undisturbed with the mother for four weeks, to reduce
the likelihood of cannibalism of the pups. At four weeks of age, the offspring were weaned and
sexed. Four male offspring were arbitrarily selected and separated into cages as potential study
rats. The remaining offspring were euthanized. At the time of weaning, the maternal SHR were
euthanized by rapid decapitation, and trunk blood was collected in both heparinized and clotting
tubes. Maternal hematocrit, weight, and stress level were recorded. Serum was separated and
frozen for later analysis of plasma aldosterone and corticosterone. At 11-13 weeks of age, two of
the four male offspring were arbitrarily selected from each second litter and implanted with a
remote monitoring device to record cardiovascular parameters. The extra males were used if an
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implant surgery was unsuccessful. Once two pups were successfully implanted, any remaining
pups from that litter were euthanized by CO2 inhalation.

PA-C40 Implantation
At 11-13 weeks of age, the SHR male offspring were surgically implanted with a remote
monitoring device used to collect data on blood pressure, heart rate, and activity level. The
remote blood pressure monitoring device (PA-C40) consists of a transmitter and catheter. The
implants remained in the SHR male offspring for four weeks to allow for four weeks of data
collection.
The implantation surgery was performed as follows. The sterilized BP monitoring
device (PA-C40, Data Sciences International, St. Paul, MN) was placed into a beaker of sterile
saline. The rat was shaved to prevent hair from entering the sterile surface surrounding the
incision. The shaved area included both the legs and the caudal half of the ventral abdomen. A
2-3 cm inguinal incision was made perpendicular to the femoral groove. Blunt dissection was
used to part the fat and connective tissue surrounding the femoral artery. The most proximal
section of the femoral artery was isolated.
Three sutures were preplaced around the isolated section of the femoral artery. The
proximal suture was used to temporarily occlude blood flow while the catheter was inserted. The
middle suture was used to seal the artery around the catheter stem. The distal occlusion suture
was used to permanently ligate the downstream artery. Once the sutures were preplaced, a
secure knot was tied around the downstream suture. The catheter introducer consisted of a 22
gauge injection needle with the tip bent 90˚ away from the bevel to allow for the open part of the
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bevel to face down when the needle was held vertically. Tension was applied to the downstream
occlusion suture and it was anchored it to the sterile work area using tape. A heavy hemostat
was then applied to the upstream occlusion suture to produce tension and occlude the blood flow.
The middle suture was then loosely tied, and would be tightened to secure the catheter in place
once it was introduced into the vessel. The transmitter catheter was then placed in close
proximity to the incision site. The pointed bevel on the bent needle was inserted into the lumen
of the femoral artery just proximal to the downstream ligation suture, and the catheter was fed
into the vessel lumen. The proximal suture was then released to allow the catheter to be gently
inserted further into the artery until approximately 1.5 inches of catheter remained outside. This
insured the tip of the catheter was seated properly in the aorta. The middle occlusion suture was
repositioned over the artery and catheter, and tied into a knot. The upstream occlusion suture
was tied around the artery and catheter as well. The loose ends of the downstream occlusion
suture were tied around the catheter stem.
After the catheter was secured and knotted, blunt dissection was used to tunnel under the
skin on the ipsilateral side of the rat to create a pocket for placement of the transmitter. The
pocket was made cranial enough not to interfere with the hind leg. The tunnel was then irrigated
with sterile saline prior to the insertion of the transmitter. The transmitter was inserted battery
end first into the opening, making sure the skin was not excessively tight over the transmitter
body. A suture was then placed to anchor the skin to the body on the inside of the animal’s
flank, which prevented the transmitter from migrating back to the inguinal region. Once the
transmitter was placed correctly, the skin was closed with sterile monofilament nylon suture (40; 3/8 circle cutting needle; Henry Shein). The rat was injected with buprenorphine (0.3 mg/kg
subcutaneously) and placed in a cage for recovery and data collection.
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The remote monitoring device sends blood pressure data via radio signal to a receiver
connected to a computer. The receiver was placed directly under the rat’s cage. The computer
was programmed to record 15-second segments, once an hour for 48 successive hours during
each of the 4 weeks of data collection, which began within a few days of implantation. Batteries
were shut off during the days the rats were not monitored to conserve battery life. After the
fourth week of monitoring, rats were euthanized by rapid decapitation and trunk blood was
collected. Hematocrit was measured, and serum was separated and frozen for later analysis of
plasma aldosterone and corticosterone. The implant devices were removed, cleaned, resterilized, and implanted into the next rat.

Euthanasia by Rapid Decapitation
Rapid decapitation is the only well accepted means available to collect blood prior to
minimize stress-initiated elevation of plasma aldosterone and corticosterone levels. SHR were
quickly coaxed into a plastic “restraining bag” (Harvard Apparatus), and decapitated, using a
guillotine, within 2 minutes of restraint. Trunk blood was collected into a serum separator tube
and a heparinized test tube using funnels. The small heparinized blood sample was used for
hematocrit analysis. Hematocrit analysis was used to indicate the proportion of blood made up
of red blood cells to determine if the animals had an excess destruction of red blood cells, or a
reduction in red blood cells. Hematocrit analysis also indicates if rats were dehydrated at the
time of collection. Serum was stored at -80°C until hormone analysis.
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RIA of Plasma Hormones
Radioimmunoassay kits for aldosterone and corticosterone were obtained from Siemens
Healthcare Diagnostics (Coat-A-Count Corticosterone, Catalog number TKRC1, DPC). Assay
procedures followed the manufacturer’s directions (Appendix). All samples were assayed at one
time to eliminate inter-assay variability.

Data Collection and Analysis
The PA-C40 transmitter measured cardiovascular parameters and activity in SHR
offspring. The transmitter consisted of a pressure catheter that transfers pressure from the
catheter to a pressure sensor in the transmitter body. The implanted device was turned on or off
by waiving a magnet over the outside of the rat. Once the battery implant was turned on, the
remote monitor began to collect data. Data were collected approximately 2 ½ days per week
during which the computer was set to take a 10 second sample each hour. Data were collected
for four weeks following implantation and included the following: systolic (mmHg), diastolic
(mmHg), and mean blood pressure (mmHg), heart rate (beats per minute), and activity level.
Activity level was determined from rat movement patterns. When the rat’s hind limb moved (the
side the catheter was inserted), the catheter and transmitter moved as well. The activity sensed
by the transmitter was sent to the receiver and was designated a relative number corresponding to
the movement pattern. The data were recorded using the Dataquest A.R.T. software package
with factory supplied calibration values (Data Science International).
Systolic, diastolic, and pulse pressure, mean arterial pressure, heart rate, and activity level
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were compared using a one way ANOVA to evaluate same age data points between freeze and
sham groups. The data were sorted by activity first with the following relative designations: low
(0-2), moderate (2-4), and high activity (4-8). A two-way ANOVA was used to compare data
points over time between groups. Tukey/Kramer post hocs tests were performed where
significance was found.
A continuous scatterplot with linear regression analysis compared activity level versus
mean pressure for each week of the four week data collection period. The slopes and elevations
of the regression lines from the sham and frozen groups were compared using a two-way
ANOVA.
A t-test was used to compare plasma corticosterone and aldosterone levels between
groups. Additionally, maternal and offspring hematocrits were compared using a t-test in sham
and frozen treatments. All differences were considered significant at p < 0.05.
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Chapter IV
Results
General
No significant age/weight differences were found in maternal rats subjected to either the
sham or freeze procedure (73.6+1.8 vs. 71.9+2.5 days) at the time of adrenal freezing. However;
maternal frozen rats were heavier on average at the time of surgery but, not significantly
(206+6.7 vs. 226+10.7 grams; P=0.09). The SHR pups were then separated from their mothers
after 4 weeks of weaning. No significant difference was found between sham and frozen
maternal weight at the time of weaning (255+13 vs. 263+14 grams). Also, no significant
difference was observed when calculating the difference between maternal weight at the time of
surgery and maternal weight at the time of weaning (47.9+7.5 vs. 37.4+8.4 grams) (Table 1).
A total of 30 pups from sham (n=16) and adrenal frozen (n=14) mothers were surgically
implanted with a remote monitoring device that collected data on heart rate, activity level,
systolic, diastolic, pulse, and mean arterial blood pressure. When comparing timeline data, no
differences were found in the time span between any of the following: time between the
maternal sham/freeze date and offspring date of birth (37.6+0.5 vs. 37.1+1.0 days), between the
offspring date of birth and implant date (84.6+1.6 vs. 83.4+1.3 days), or between the implant
date and the time of first data collection (3.05+0.9 vs. 3.00+0.8 days) with sham and adrenal
frozen values reported respectively (Table 1).
Pup weights at the time of implantation and euthanasia were not significantly different in
sham versus adrenal frozen groups, although the offspring of adrenal frozen rats were slightly
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heavier (280+5 vs. 294+7 grams at implantation; P=0.082 and 334+1 vs. 348+6 grams at
euthanasia; P=0.088). However, the difference between implantation weight and euthanasia
weight (weight gain) was similar (53.9+3.3 vs. 53.8+1.0 grams) (Table 1).

Hematocrit Levels
Maternal and offspring hematocrit levels were measured after rapid decapitation and
trunk blood collection. Hematocrit levels are recorded as the percent volume of blood that is
composed of cells. No significant differences in hematocrit levels were observed between sham
and adrenal frozen groups in the maternal rats (42.8+1.8 vs. 44.7+3.0 %, respectively), or in the
offspring (46.2+1.4 vs. 45.9+1.5 %) (Figure 1, Table 2).

Plasma Hormone Levels
Two rat serum samples were removed from the hormone analysis (one from each group)
based on laboratory notebook records indicating elevated stress levels at the time of decapitation
and markedly elevated plasma corticosterone and aldosterone values. Plasma corticosterone
levels were not significantly different between sham and adrenal frozen mothers (156+39 vs.
167+74 ng/dL). Pups from the adrenal frozen mothers had a reduced level of corticosterone
compared to pups from sham mothers (57.8+20 vs. 140+41 ng/dL; P=0.079) (Figure 2), but this
difference was not significant. Plasma aldosterone was significantly lower in the adrenal frozen
mothers (2.97+0.8 vs. 0.54+0.4 ng/dL) versus the sham (P=0.013). Plasma aldosterone levels
were not different in the pups between the two groups (6.99+2.5 vs. 3.87+2.1 ng/dL) (Figure 3),
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(P=0.332) (Figure 2, Table 3)

Cardiovascular Parameters
SHR offspring were implanted with a PA-C40 remote monitoring device to record
cardiovascular parameters including heart rate, activity level, systolic, diastolic, pulse, and mean
arterial blood pressure. The pulse pressure, mean arterial pressure, systolic pressure, and
diastolic pressure were averaged for each week for each rat at low (0-2), moderate (2-4), and
high (4+) activity levels (Figures 3, 4, 5; Tables 4, 5, 6). Group means for each activity level and
week was calculated from the individual rat mean values, and levels were compared between
offspring from sham and adrenal frozen mothers.
No significant differences were observed in heart rate, systolic, pulse, diastolic, and mean
arterial blood pressure in low, moderate, and high activity levels in any of the four weeks
between sham and adrenal frozen offspring. A trend was visible in that systolic, diastolic, and
mean arterial pressures were consistently higher in the sham group than in the adrenal frozen
group, across all ages and activity levels. Within group differences were observed between low,
moderate, and high activity levels but no significant differences were found between groups at
each activity level (Figures 3, 4, 5; Tables 4, 5, 6).
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Regression Data on Blood Pressure versus Activity Level
A scatterplot with a regression line compared activity level versus mean pressure for each
of the four weeks of data collection (Figures 5, 6, 7). The slopes and elevations of the regression
lines from the sham and frozen groups were compared using a two-way ANOVA.
When plotted against activity, there was no was no significant difference in pulse
pressure values comparing slopes between groups during any weeks (Figure 5). Heart rate
showed similar results for weeks 1, 2, and 3, but the regression slope for week 4 was
significantly more shallow in the adrenal frozen group that in the sham (P=0.016) (Figure 6).
When plotted against activity, mean arterial pressure had a significantly more shallow
slope during weeks 2 and 3, (P<0.001; P=0.049), and had a lower overall elevation during weeks
1 and 4 (P=0.033; P<0.001) (Figure 7).
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Chapter V
Discussion
Overview
A significant reduction in maternal aldosterone was observed in SHR subjected to
unilateral adrenalectomy and a contralateral zona glomerulosa freezing procedure indicating that
the fetuses of the adrenal freeze procedure had compromised aldosterone levels during gestation.
Maternal corticosterone levels did not differ significantly between the two groups. Male SHR
pups in the two groups did not demonstrate significant differences in plasma aldosterone or
corticosterone levels. The maternal adrenal freezing procedure was found to significantly reduce
the slope of the mean pressure of male offspring when plotted against activity level during weeks
2 and 3 of the study. Mean arterial pressure of offspring in the adrenal frozen group was
significantly lower than sham offspring during week 4. A similar trend was visible during week
1 but, this was not physiologically significant. Pulse pressure was significantly lower (overall) in
most weeks, but the mean difference was only 1 mm, which is not physiological significant.
Heart rate also was significantly lower most weeks, but the difference was only 5 bpm, which is
not physiologically significant given that heart rates were greater than 300 bpm. Heart rate
followed a similar trend as mean pressure, showing a shallower slope when plotted against
activity. However, this was only significant during week 4.
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Plasma Hormone Levels
The adrenal freeze procedure was found to significantly lower maternal plasma
aldosterone concentrations but did not alter corticosterone concentrations in maternal SHR
(P=0.013 and P=0.882, respectively). Although these values were obtained four weeks post
parturition, prior studies in this lab have shown that adrenal freezing of maternal rats prior to
mating lowers aldosterone but not corticosterone when measured on day 21 of gestation. These
results suggest that the adrenal freeze procedure successfully altered zona glomerulosa cell
function without compromising hormone secretion in the other layers of the adrenal cortex.
Offspring concentrations of plasma aldosterone and corticosterone were not significantly
different between sham and frozen groups.
The reduction in maternal aldosterone synthesis will affect the supply of aldosterone to the fetus
because maternal circulation of aldosterone and other steroid hormones can cross into the fetus
through the placenta (65). Since zona glomerulosa cells are not present in the fetus until
gestational day 16, maternal aldosterone secretion is important for fetal development.
Immunohistochemistry and in situ hybridization was used to determine the expression of
P450aldo in the adrenal cortex of rats (66). P450aldo, a chemical marker indicating the
production of aldosterone synthase, was present in small amounts in the adrenal cortex at day 16
of gestation. P450aldo distribution changed by gestational day 19, into a discontinuous ring of
cells 4- to 5-cells wide under the capsule, forming the functional zona glomerulosa (66).
Therefore, alterations in the maternal adrenal hormones would have an effect on the hormone
levels in the developing fetus until the zona glomerulosa is fully developed until at least
gestational day 18-19 (18, 66).
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Growth
The reduction in aldosterone synthesis in maternal frozen rats did not appear to affect
offspring growth, since offspring weights at 11-13 weeks of age were not significantly different
between groups. Although it is possible that offspring weights were reduced at birth, prior
studies in this lab have found no difference in fetal weights between maternal adrenal frozen and
control groups at day 21 of gestation. Aldosterone plays a role in blood volume expansion
during pregnancy (67, 68), and lower aldosterone would be expected to reduce maternal blood
volume which could potentially affect fetal growth. Furthermore, aldosterone appears necessary
for normal placental development since aldosterone deficient mice produced fewer and smaller
offspring (51, 52). The potential for reduced aldosterone to alter fetal development has been
demonstrated in a study which observed the effect on cultured embryos of blocking
adrenocortical hormones with ZK 91587, a mineralocorticoid receptor antagonist (69). When
receptor activity was obstructed, damaging effects on embryonic development occurred. The
effect of the mineralocorticoid antagonist was found to be reversed by the direct administration
of aldosterone to the embryos by infusion. Adverse effects on rat embryos observed included
reduced total length, somite number, compromised communication between the vitelline and
umbilical cord, impaired vascularization of the vitelline sac, and reduced embryo curvature (69).
The absence of a fetal growth effect in the present study may be due to aldosterone not being
lowered enough to significantly decrease maternal fluid and blood volume, or to impair placental
development. It is also possible that other hormones such as corticosterone may contribute to the
expansion of blood volume that occurs during gestation (67, 70).
Few studies have examined lowered aldosterone during pregnancy, but several have
looked at altered maternal sodium intake. Sodium intake has a profound effect on aldosterone,
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through its influence on the renin-angiotensin aldosterone system (RAAS). Maternal low
sodium diets have been shown to lower maternal blood volume, and activate the RAAS,
increasing maternal and fetal aldosterone levels (71). Maternal high sodium diets expand
maternal blood volume and suppress the RAAS, reducing plasma aldosterone levels (72). Thus
alterations in maternal sodium intake could produce blood volume effects similar to those
produced by alterations in aldosterone (71).
Maternal sodium alterations have been shown to affect fetal development. Deloof et al.
(2000) studied the effects of high maternal sodium intake during late gestation on maternal and
fetal hormone secretion and body growth in WKY rats (72). The results of the study found no
change in maternal weight when sodium intake was altered, although fetal weight did increase in
response to the high salt diet. The increase in fetal body weight was attributed to the increase in
water retention associated with a sodium increase (72), however alterations in the RAAS were
not ruled out as a mechanism. Other studies have found that a low sodium diet in maternal rats
reduced plasma volume, increased aldosterone and induced growth restriction in the fetuses (73,
74, 75). However, by 14 days of age, pups were of normal size (73, 75). A high sodium diet
would result in low maternal aldosterone, similar to our study, while a low sodium diet would
raise maternal aldosterone. Deloof found that the high salt diet caused nearly a 50% decrease in
plasma aldosterone in pregnant rats and fetal rats (72). The decrease in aldosterone from the
high salt diet is due to the reduction in the maternal renin-angiotensin-aldosterone system, which
reduces aldosterone secretion. While the adrenal freeze procedure may produce aldosterone
concentrations that mirror the results of a high sodium diet, the changes are not attributed to
alterations in renin and angiotensin. Furthermore, the rats in the current study would not likely
have water retention, but would more likely have volume depletion.
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Hematocrit
No significant differences in hematocrits were observed between sham and adrenal
frozen groups in the maternal rats (42.83+1.79 vs. 44.71+3.00 %, respectively), or in the
offspring (46.18+1.41 vs. 45.91+1.48 %). Deloof et al (2000) found no change in fetal
hematocrit levels of maternal WKY given a high sodium diet despite changes in plasma
aldosterone concentrations and sodium intake (72). In the current study, adrenal freezing
lowered plasma aldosterone levels, and may have produced lower maternal blood volumes.
However, a lower blood volume will not necessarily influence hematocrit levels. If the
concentration of red blood cells remains constant, hematocrit levels will remain normal
regardless of the total blood volume (76).

Mean Arterial Pressure
Blood pressure did not increase as much with activity in the offspring of the adrenal
frozen group versus the control group for weeks 2 and 3, and was overall lower during week 4.
Blood pressure is a function of heart rate, stroke volume, and vascular resistance. Heart rate also
showed a lower rate of increase with activity in the adrenal frozen group than in the control
group. Pulse pressure, known to be related to stroke volume, had an overall slight decrease in
the adrenal frozen group, but this change was small (1 mmHg). Although pulse pressure and
heart rate changes were not significant individually, together they may explain, in part, the
observed changes in mean arterial pressure. An increase in sympathetic nervous system activity
occurs with an increase in activity, producing the higher heart rates, stroke volumes, and mean
arterial blood pressures observed during exercise. A lesser increase in sympathetic stimulation
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with activity could explain the current results (77, 78, 79). During the 4th week, the overall
mean pressure was lowered, but the mean arterial pressure response to activity returned to
normal in the adrenal frozen group.
A reduction in blood volume could explain the lower blood pressure during week 4.
However, if the adrenal frozen group offspring had been volume depleted, a smaller pulse
pressure and faster heart rate would have been expected, but this did not occur. Therefore, it is
unlikely that volume depletion caused this reduction in mean arterial pressure. Both pulse
pressure and heart rate tended to be lower during week 4, suggesting an overall lower level of
sympathetic nervous system stimulation (77, 78, 79).
The mechanism underlying the alterations in the cardiovascular system of the offspring of
the adrenal frozen rats is unclear. Reduced maternal plasma volume could have occurred as a
result of low aldosterone. A study in sheep found fetal arterial pressure to be significantly
related to maternal plasma volume, which was altered by lowering aldosterone or cortisol (67).
The authors concluded that maternal volume expansion may be necessary for normal fetal blood
pressure, glucose levels, and blood oxygen tension, and that normal adrenal secretion is
necessary for maternal and fetal homeostasis. Although fetal blood pressure was reduced with
low aldosterone, blood pressure was not monitored in the lambs after birth.
Alterations in maternal sodium diet can affect maternal plasma or blood volume, and alter
plasma aldosterone levels. Several studies have found that altered maternal sodium can affect
offspring cardiovascular homeostasis. High sodium maternal diets have been shown to result in
higher mean arterial blood pressure in rat offspring (48, 70) and increase the responsiveness of
the RAAS (75). Koleganova et al (2011) found that both high and a low maternal salt intake can

37

raise mean arterial blood pressure in the offspring. High sodium diets also increase the
sympathetic activation in response to stress (48, 81). None of the alterations in maternal sodium
intake appeared to confer the beneficial effects on the offspring cardiovascular system that were
observed with the reduced maternal aldosterone of the present study. Low sodium diets likely
reduce plasma or blood volume in the maternal rat, as would be expected in the current low
aldosterone model. High sodium diets would likely suppress maternal aldosterone, again similar
to the current study. However, the combination of low aldosterone and reduced blood volume is
not likely observed with either diet, and this may explain the different effects noted in the present
study.

Conclusion
This study was designed to investigate in SHR, the effects of maternal aldosterone
suppression on the development of hypertension in the offspring. The freeze procedure, right
adrenalectomy combined with cryodestruction of the zona glomerulosa of the left adrenal gland,
successfully reduced maternal aldosterone concentrations and influenced fetal development
leading to changes in adult offspring cardiovascular function. The adult offspring of the adrenal
frozen group were found to have an attenuated mean pressure response to activity during weeks
2 and 3, and an overall lower mean pressure during week 4. Similar patterns in heart rate suggest
that an attenuation of sympathetic activation with increased activity was likely responsible for
the group differences. This fetal programming effect has not been observed with other maternal
manipulations involving aldosterone.
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Appendix
The serum samples were taken out of the freezer (plasma frozen at -80°C) and thawed to
room temperature overnight. Four uncoated polypropylene plain tubes (12x75mm) were labeled
in duplicate for non-specific binding and total count. Corticosterone Ab-coated tubes A through
H were labeled in duplicate for the calibrators used to calculate a standard curve. Duplicate tubes
were also labeled for each rat serum sample. Samples were pipetted into the bottom of the tubes.
50µL of zero calibrator A was pipetted into A and non-serum binding (NSB) tubes. In addition,
50µL of the each calibrator (standard) was pipetted into tubes B through H, and 50µL of each
serum sample was pipetted into the appropriate tube. 1.0mL of 125I Rat Corticosterone was
added to each tube, and the tubes were vortexed briefly to mix. The tubes were then incubated
for 2 hours at room temperature allowing for the antibodies to bind, and then all tubes except the
T (total counts) tubes were decanted. In order to remove any visible contents remaining in the
tube, all tubes (except for the T tubes) were turned over and struck against absorbent paper. The
samples and duplicates were then placed into a gamma counter (Ludum Measurements, Model
2600) for 1 minute to read tube radioactivity. The CPM (counts per minute) was recorded for
each tube on the corticosterone assay data sheet. Duplicate counts were averaged. The results
from the calibration samples were organized into a standard logit-log curve, and an equation was
calculated and used to determine plasma corticosterone levels from the sample counts.
The radioimmunoassay procedure for rat aldosterone (Coat-A-Count Aldosterone,
Catalog number TKAL1,DPC) followed a similar procedure to that of rat corticosterone.
Aldosterone Ab-Coated tubes were labeled in duplicate A through G for the calibrators. Plain
plastic tubes were labeled with NSB and T, and aldosterone Ab-coated tubes were labeled in
duplicate for each rat serum. 200µL of calibrator A was added to the NSB tubes, 200µL of each
47

calibrator was added to tubes labeled A through G, and 200µL of each serum sample were
pipetted according to their respective rat identification tags. 1.0mL of 125I Rat Aldosterone was
also added to each tube, which was then vortexed briefly. The tubes incubated for 18 hours at
room temperature to allow for the antibodies to bind, were decanted, and then were read for 1
minute in the gamma counter. Recorded CPM of each sample and its duplicate were averaged,
and a standard logit-log curve and equation were calculated. The equation was used to determine
rat serum aldosterone levels.
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Table 1. Weights and timeline data from maternal and offspring sham (n=10; n=16) and adrenal frozen (n=8;
n=14) SHR.

General Weight and Timeline Statistics
Sham
Frozen
P-value
Maternal weight
at the time of
206+7
226+11
0.092
surgery
Maternal weight
at euthanasia

255+13

263+14

0.644

Offspring weight
at the time of
implant

280+5

294+7

0.082

Offspring weight
at the time of
euthanasia

334+6

348+6

0.088

Time from
surgery to birth
of pups (days)

38+1

37+1

0.675

Pups age at
implant (days)

85+2

83+1

0.588

Implant to start
of data collection
(days)

3.1+1

3.0+1

0.968
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Table 2. Hematocrit values for maternal and offspring SHR for the sham and adrenal frozen groups. Blood was
collected four weeks after parturition (approximately 12 weeks after the sham/freeze procedure) in the mothers, and after
four weeks of data collection (14-16 weeks of age) in the offspring.

Hematocrit
Mothers
Sham
Mean
SE

42.8
1.8

Freeze
44.7
3.0

Offspring
Sham
46.2
1.4

Freeze
45.9
1.5
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Table 3. Plasma hormone values for maternal and offspring SHR for the sham and adrenal frozen groups are shown below.
Blood was collected four weeks after parturition (approximately 12 weeks after the sham/freeze procedure) in the mothers,
and after four weeks of data collection (14-16 weeks of age) in the offspring.

Plasma Hormone Levels
Aldosterone
Corticosterone
Offspring
Mothers
Offspring
Mothers
Sham
Freeze
Sham
Freeze
Sham
Freeze
Sham Freeze
Mean
7.0
3.9
3.0
0.5
140.0
57.8
156.0
167.1
SE
2.5
2.1
0.7
0.4
40.7
20.3
39.3
73.6
P-value
0.3327
0.0128*
0.0793
0.8823
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Table 4. Cardiovascular parameters measured by an implanted remote monitoring device during low activity levels
in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were found.

Cardiovascular Parameters: Low Activity
Wk 1

Wk 2

Wk 3

Wk 4

Sham

Frozen

Sham

Frozen

Sham

Frozen

Sham

Frozen

Pulse P

50.7+2.6

51.6+1.2

55.0+2.0

56.2+1.1

56.5+2.1

55.6+0.9

57.0+2.2

53.2+2.2

Systolic

172+4

171+2

174+3

172+1

178+3

174+2

179+3

175+2

Mean P

146+4

144+2

146+3

143+1

149+3

146+1.5

149+3

147+2

HR

383+7

380+5

363+5

360+4

355+5

358+5

360+6

350+4

Diastolic

121+3

119+2

119+3

116+1

122+3

119+1

122+3

121+2

Activity

5.43+0.2

5.76+0.2

5.39+0.2

5.38+0.2

5.50+0.2

5.26+0.3

5.32+0.2

5.21+0.2
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Table 5. Cardiovascular parameters measured by an implanted remote monitoring device during moderate activity
levels in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were found.

Cardiovascular Parameters: Moderate Activity
Wk 1

Wk 2

Wk 3

Wk 4

Sham

Frozen

Sham

Frozen

Sham

Frozen

Sham

Frozen

Pulse P

51.4+2.0

52.0+1.2

54.0+2.1

55.6+1.1

56.2+2.2

54.5+0.8

54.9+2.5

52.2+1.9

Systolic

173+2.5

172+2

171+2

171+2

178+3

172+2

175+3

170+2

Mean P

147+2.1

146+2

143.5+2

143+2

149+2

144+2

147+3

143+2

HR

372+5

371+6

353+5

355+3

354+6

355+6

342+5

348+4

Diastolic

122+2

120+2

117+2

115+1

122+3

118+2

121+3

118+2

Activity

2.79+0.1

3.00+0.1

2.98+0.1

2.85+0.0

2.90+0.1

2.83+0.1

2.90+0.0

2.89+0.1
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Table 6. Cardiovascular parameters measured by an implanted remote monitoring device during high activity
levels in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were
found.

Cardiovascular Parameters: High Activity
Wk 1

Wk 2

Wk 3

Wk 4

Sham

Frozen

Sham

Frozen

Sham

Frozen

Sham

Frozen

Pulse P

50.7+2.5

51.6+1.2

55.0+2.0

56.2+1.1

56.5+2.1

55.6+0.9

57.0+2.2

53.2+2.2

Systolic

172+4

171+2

174+3

172+1

178+3

174+2

179+3

175+2

Mean P

146+4

144+2

146+3

144+1

149+3

146+2

149+3

147+2

HR

383+7

380+5

363+5

360+4

355+5

358+5

360+6

350+4

Diastolic

121+3

119+2

119+3

116+1

122+3

119+1

122+3

121+2

Activity

5.43+0.2

5.76+0.2

5.39+0.2

5.38+0.2

5.50+0.2

5.26+0.3

5.32+0.2

5.21+0.2
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Maternal Hematocrit

Offspring Hematocrit

50
49
48
47

PCV (%)

46

45
44
43
42
41
40
Sham

Freeze
Treatment

Sham

Freeze
Treatment

Figure 1. Hematocrit values for SHR mothers and offspring in the adrenal frozen or sham group. Blood was collected four weeks
after parturition (approximately 12 weeks after the sham/freeze procedure) in the mothers, and after four weeks of data collection
(14-16 weeks of age) in the offspring. No significant differences were observed between groups in either the maternal or offspring
SHR.
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*

Figure 2. Plasma aldosterone and corticosterone concentrations for both maternal and offspring SHR in both sham and adrenal frozen
groups are displayed above. Serum was collected immediately after decapitation. Significant difference in maternal frozen rats
compared to sham (*P<0.05).
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Figure 3. Cardiovascular parameters measured by an implanted remote monitoring device during low activity levels
in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were found.
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Figure 4. Cardiovascular parameters measured by an implanted remote monitoring device during moderate activity
levels in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were
found.
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Figure 5. Cardiovascular parameters measured by an implanted remote monitoring device during high activity levels
in SHR male offspring of adrenal frozen or sham operated maternal rats. No significant differences were found.
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Figure 6. Best fit regression lines for Pulse Pressure versus activity in each of the 4 weeks of data collection in SHR offspring
in the sham and adrenal frozen groups. The line slopes were not significantly different.
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Figure 7. Best fit regression lines for heart versus activity in each of the 4 weeks of data collection in SHR offspring in
the sham and adrenal frozen groups. The line slopes were significantly different during week 4.
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Figure 8. Best fit regression lines for mean arterial pressure (MAP) versus activity in each of the 4 weeks of data collection in
SHR offspring in the sham and adrenal frozen groups. The line slopes were significantly different during weeks 2 and 3, and the
line for the adrenal frozen group was significantly lower than the sham group during week 4.
62

63

